Jiangsu Apon Medical Technology Co., Ltd. (SHE:300753)
China · Delayed Price · Currency is CNY 34.42
+1.16 (3.49%)
At close: Feb 13, 2026
SHE:300753 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Operating Revenue | 379.2 | 402.3 | 420.79 | 323.38 | 460.72 | 442.75 |
Other Revenue | 1.5 | 1.5 | 1.38 | 0.43 | 0.49 | 0.32 |
| 380.7 | 403.8 | 422.17 | 323.81 | 461.21 | 443.08 | |
Revenue Growth (YoY) | -5.09% | -4.35% | 30.38% | -29.79% | 4.09% | 16.71% |
Cost of Revenue | 130.95 | 127.74 | 145.71 | 163.82 | 166.33 | 188.59 |
Gross Profit | 249.74 | 276.06 | 276.46 | 159.99 | 294.88 | 254.48 |
Selling, General & Admin | 232.68 | 231.61 | 228.59 | 207.17 | 199.73 | 137.54 |
Research & Development | 38.78 | 33.28 | 36.55 | 34.95 | 43.98 | 23.55 |
Other Operating Expenses | -14.22 | -13.03 | -8.28 | -2.53 | -3.78 | -5.9 |
Operating Expenses | 262.24 | 258.06 | 264.8 | 240.71 | 246.76 | 158.21 |
Operating Income | -12.5 | 18 | 11.66 | -80.72 | 48.12 | 96.28 |
Interest Expense | -3.2 | -3.07 | -3.04 | -2.47 | -1.13 | -0 |
Interest & Investment Income | 2.66 | 1.98 | 2.27 | 3.51 | 4.46 | 8.49 |
Currency Exchange Gain (Loss) | 0 | 0 | - | - | - | - |
Other Non Operating Income (Expenses) | 3.28 | -0.06 | -0.06 | -0.06 | -0.1 | -0.09 |
EBT Excluding Unusual Items | -9.76 | 16.86 | 10.84 | -79.75 | 51.35 | 104.68 |
Impairment of Goodwill | - | - | - | -16.16 | - | - |
Gain (Loss) on Sale of Investments | -0.79 | -1.38 | -1.44 | - | - | - |
Gain (Loss) on Sale of Assets | -0.01 | 3.59 | 0.01 | -0.02 | - | - |
Asset Writedown | -0.75 | -0 | -0 | -0.01 | -0 | -0.01 |
Other Unusual Items | 2.11 | 2.11 | 4.41 | 5.24 | 3.95 | 7.24 |
Pretax Income | -9.19 | 21.17 | 13.81 | -90.71 | 55.3 | 111.91 |
Income Tax Expense | -3.93 | 10.27 | 5.36 | -14.59 | 1.98 | 15.04 |
Earnings From Continuing Operations | -5.27 | 10.89 | 8.45 | -76.12 | 53.32 | 96.87 |
Minority Interest in Earnings | 0.77 | -0.09 | -0.17 | 0.14 | 0.75 | 0.09 |
Net Income | -4.49 | 10.8 | 8.28 | -75.98 | 54.06 | 96.96 |
Net Income to Common | -4.49 | 10.8 | 8.28 | -75.98 | 54.06 | 96.96 |
Net Income Growth | - | 30.48% | - | - | -44.24% | -5.26% |
Shares Outstanding (Basic) | 126 | 126 | 126 | 126 | 126 | 126 |
Shares Outstanding (Diluted) | 126 | 126 | 126 | 126 | 126 | 126 |
Shares Change (YoY) | 0.06% | 0.03% | -0.05% | -0.00% | 0.00% | -0.00% |
EPS (Basic) | -0.04 | 0.09 | 0.07 | -0.60 | 0.43 | 0.77 |
EPS (Diluted) | -0.04 | 0.09 | 0.07 | -0.60 | 0.43 | 0.77 |
EPS Growth | - | 30.44% | - | - | -44.24% | -5.26% |
Free Cash Flow | -11.46 | 5.45 | -54.07 | -48.76 | -21.31 | 47.7 |
Free Cash Flow Per Share | -0.09 | 0.04 | -0.43 | -0.39 | -0.17 | 0.38 |
Dividend Per Share | 0.065 | 0.065 | 0.065 | - | - | 0.250 |
Dividend Growth | - | - | - | - | - | -2.50% |
Gross Margin | 65.60% | 68.37% | 65.49% | 49.41% | 63.94% | 57.44% |
Operating Margin | -3.28% | 4.46% | 2.76% | -24.93% | 10.43% | 21.73% |
Profit Margin | -1.18% | 2.67% | 1.96% | -23.46% | 11.72% | 21.88% |
Free Cash Flow Margin | -3.01% | 1.35% | -12.81% | -15.06% | -4.62% | 10.77% |
EBITDA | 2.26 | 31.86 | 24.33 | -66.97 | 60.9 | 105.98 |
EBITDA Margin | 0.59% | 7.89% | 5.76% | -20.68% | 13.21% | 23.92% |
D&A For EBITDA | 14.76 | 13.86 | 12.67 | 13.76 | 12.78 | 9.7 |
EBIT | -12.5 | 18 | 11.66 | -80.72 | 48.12 | 96.28 |
EBIT Margin | -3.28% | 4.46% | 2.76% | -24.93% | 10.43% | 21.73% |
Effective Tax Rate | - | 48.53% | 38.81% | - | 3.58% | 13.44% |
Revenue as Reported | 380.7 | 403.8 | 422.17 | 323.81 | 461.21 | 443.08 |
Advertising Expenses | - | 24.34 | 31.35 | 27.28 | 16.48 | 8.06 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.